Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D in coronary artery disease with postchallenge hyperglycemia and vitamin D deficiency
2009-015776-95Phase 4Completed
- Sponsor
- Medical University of Graz, Department of Endocrinology and Metabolism
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of AIDWELL-D3 in coronary arteriosclerosis, postchallenge hyperglycemia (PCH) and Vitamin D deficiency (VDD), sponsored by Medical University of Graz, Department of Endocrinology and Metabolism. Primary endpoint: Changes in endothelial dysfunction (peripheral artery tone and biochemical markers). Started Mar 2010; status: completed.
02
Drugs
AIDWELL-D3
03
Conditions
coronary arteriosclerosispostchallenge hyperglycemia (PCH)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2009-015776-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015776-95.